Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond

Por Zhu, Jason, Armstrong, Andrew J., Friedlander, Terence W., Kim, Won, Pal, Sumanta K., George, Daniel J., Zhang, Tian
Publicado no J Immunother Cancer (2018)

Posttraumatic Stress and Depressive Symptoms in Renal Cell Carcinoma: Association with Quality of Life and Utility of Single Item Distress Screening

Por Thekdi, Seema Malhotra, Milbury, Kathrin, Spelman, Amy, Wei, Qi, Wood, Christopher, Matin, Surena F., Tannir, Nizar, Jonasch, Eric, Pisters, Louis, Cohen, Lorenzo
Publicado no Psychooncology (2015)

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

Por Procopio, G, Bellmunt, J, Dutcher, J, Bracarda, S, Knox, J, Brueckner, A, Molnar, I, Escudier, B, Hutson, T E
Publicado em 2013

Endourooncology new horizons in endourology /

Por Kumon, Hiromi., Murai, Masaru., Baba, Shiro.
Publicado em 2005

Hepatitis B reactivation related to everolimus

Por Sezgin Göksu, Sema, Bilal, Şerife, Coşkun, Hasan Şenol
Publicado em 2013

Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma

Por Gatto, Francesco, Nookaew, Intawat, Nielsen, Jens
Publicado em 2014

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Por Sciacovelli, Marco, Gonçalves, Emanuel, Isaac Johnson, Timothy, Roberto Zecchini, Vincent, da Costa, Ana Sofia Henriques, Gaude, Edoardo, Vercauteren Drubbel, Alizee, Julian Theobald, Sebastian, Abbo, Sandra, Tran, Maxine, Rajeeve, Vinothini, Cardaci, Simone, Foster, Sarah, Yun, Haiyang, Cutillas, Pedro, Warren, Anne, Gnanapragasam, Vincent, Gottlieb, Eyal, Franze, Kristian, Huntly, Brian, Richard Maher, Eamonn, Henry Maxwell, Patrick, Saez-Rodriguez, Julio, Frezza, Christian
Publicado no Nature (2016)

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

Por Haque, Inamul, Subramanian, Arvind, Huang, Chao H., Godwin, Andrew K., Van Veldhuizen, Peter J., Banerjee, Snigdha, Banerjee, Sushanta K.
Publicado no Int J Mol Sci (2017)

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

Por Arellano, Jorge, Hernandez, Rohini K, Wade, Sally W, Chen, Kristina, Pirolli, Melissa, Quach, David, Quigley, Jane, Liede, Alexander, Shahinian, Vahakn B
Publicado no Cancer Med (2015)

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

Por Eisen, Tim, Oudard, Stéphane, Szczylik, Cezary, Gravis, Gwenaelle, Heinzer, Hans, Middleton, Richard, Cihon, Frank, Anderson, Sibyl, Shah, Sonalee, Bukowski, Ronald, Escudier, Bernard
Publicado em 2008

MONOCYTES SUBPOPULATIONS AND CHEMILUMINESCENT ACTIVITY IN PATIENTS WITH RENAL CELL CARCINOMA

Por A. A. Savchenko, A. G. Borisov, A. A. Modestov, A. V. Moshev, I. V. Kudryavtsev, O. G. Tonacheva, V. N. Koshcheev
Publicado em 2015-04-01

Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor

Por Guo, Liting, Zhang, Haijun, Chen, Baoan
Publicado no J Cancer (2017)

Personalized Medicine in Oncology

Publicado em 2022

Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Por Chand, Sourabh, Holle, Julia U., Hilhorst, Marc, Simmonds, Matthew J., Smith, Stuart, Kamesh, Lavanya, Hewins, Peter, McKnight, Amy Jayne, Maxwell, Alexander P., Cohen Tervaert, Jan Willem, Wieczorek, Stefan, Harper, Lorraine, Borrows, Richard
Publicado em 2013

The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma

Por Fu, Pin, Chen, Fuchun, Pan, Qi, Zhao, Xianda, Zhao, Chen, Cho, William Chi-Shing, Chen, Honglei
Publicado no Onco Targets Ther (2017)

Renal Cell Carcinoma with Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer

Por Bowman, IA, Pedrosa, I, Kapur, P, Brugarolas, J
Publicado no Clin Genitourin Cancer (2017)

Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau

Por John M. DiBianco, Julie Y. An, Sally Tanakchi, Zachary Stanik, Aidan McGowan, Mahir Maruf, Abhinav Sidana, Amit Lodha Jain, Akhil Muthigi, Arvin K. George, Christopher Bayne, W. Marston Linehan, Shawna L. Boyle, Adam R. Metwalli
Publicado em 2017-07-01

SEOM clinical guidelines for the treatment of renal cell carcinoma

Por Bellmunt, J., Puente, J., Garcia de Muro, J., Lainez, N., Rodríguez, C., Duran, I.
Publicado no Clin Transl Oncol (2014)

CLINICAL OBSERVATION ON TREATMENT OF A PATIENT WITH ASCENDING COLON CANCER OCCURRING DURING...

Por O. A. Vlasov, Yu. M. Timofeyev
Publicado em 2015-02-01

Pseudohypoxia Induced by miR-126 Deactivation Promotes Migration and Therapeutic Resistance in Renal Cell Carcinoma

Por Liu, Weijun, Chen, Hanxiang, Wong, Nathan, Haynes, Wesley, Baker, Callie M., Wang, Xiaowei
Publicado no Cancer Lett (2017)